Influence of vascular endothelial growth factor on the expression of insulin-like growth factor-II, insulin-like growth factor binding protein-2 and 5 in human luteinized granulosa cells

References

• Kwintkiewicz J, Giudice LC. The interplay of insulin-like growth factors, gonadotropins, and endocrine disruptors in ovarian follicular development and function. Semin Reprod Med 2009;27:43–51.
   PubMed Web of Science ®Google Scholar
• el-Roeiy A, Chen X, Roberts VJ, Shimasakai S, Ling N, LeRoith D, Roberts CT Jr, Yen SS. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 1994;78:1488–1496.
   PubMed Web of Science ®Google Scholar
• Ramasharma K, Li CH. Human pituitary and placental hormones control human insulin-like growth factor II secretion in human granulosa cells. Proc Natl Acad Sci USA 1987;84:2643–2647.
   PubMed Web of Science ®Google Scholar
• Geisthovel F, Moretti-Rojas I, Asch RH, Rojas FJ. Expression of insulin-like growth factor-II (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells. Hum Reprod 1989;4:899–902.
   PubMed Web of Science ®Google Scholar
• Voutilainen R, Miller WL. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. Proc Natl Acad Sci USA 1987;84:1590–1594.
   PubMed Web of Science ®Google Scholar
• Ferrari B, Pezzuto A, Barusi L, Coppola F. Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles. Gynecol Endocrinol 2006;22:289–296.
   PubMed Web of Science ®Google Scholar
• Grimes RW, Samaras SE, Barber JA, Shimasaki S, Ling N, Hammond JM. Gonadotropin and cAMP modulation of IGE binding protein production in ovarian granulosa cells. Am J Physiol 1992;262:E497–E503.
   Google Scholar
• Dor J, Costritsci N, Pariente C, Rabinovici J, Mashiach S, Lunenfeld B, Kaneti H, et al. Insulin-like growth factor-I and follicle-stimulating hormone suppress insulin-like growth factor binding protein-1 secretion by human granulosa-luteal cells. J Clin Endocrinol Metab 1992;75:969–971.
   PubMed Web of Science ®Google Scholar
• Chae H, Hong SH, Hong SH, Kim SH, Kim CH, Kang BM, Lee JY. Influence of tumor necrosis factor-α on estradiol, progesterone, insulin-like growth factor-II, and insulin-like growth factor binding protein-1, 2, and 3 in cultured human luteinized granulosa cells. Eur J Obstet Gynecol Reprod Biol 2007;131:176–181.
   PubMed Web of Science ®Google Scholar
• Artini PG, Monti M, Matteucci C, Valentino V, Cristello F, Genazzani AR. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol Endocrinol 2006;22:465–470.
   PubMed Web of Science ®Google Scholar
• Stouffer RL, Martínez-Chequer JC, Molskness TA, Xu F, Hazzard TM. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 2001;32:567–575.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18–32.
   PubMed Web of Science ®Google Scholar
• McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV Jr, Connolly DT, Robertson DM. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235–236.
   PubMed Web of Science ®Google Scholar
• Dahlfors G, Arnqvist HJ. Vascular endothelial growth factor and transforming growth factor-β1 regulate the expression of insulin-like growth factor-binding protein-3, -4, and -5 in large vessel endothelial cells. Endocrinology 2000;141:2062–2067.
   PubMed Web of Science ®Google Scholar
• Mathur RS, Mathur SP. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Gynecol Oncol 2005;97:206–213.
   PubMed Web of Science ®Google Scholar
• Yan Z, Weich HA, Bernart W, Breckwoldt M, Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab 1993;77:1723–1725.
   PubMed Web of Science ®Google Scholar
• Sugino N, Kashida S, Takiguchi S, Karube A, Kato H. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2000;85:3919–3924.
   PubMed Web of Science ®Google Scholar
• Davidson TR, Chamberlain CS, Bridges TS, Spicer LJ. Effect of follicle size on in vitro production of steroids and insulin-like growth factor (IGF)-I, IGF-II, and the IGF-binding proteins by equine ovarian granulosa cells. Biol Reprod 2002;66:1640–1648.
   PubMed Web of Science ®Google Scholar
• Liu XJ, Malkowski M, Guo Y, Erickson GF, Shimasaki S, Ling N. Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells. Endocrinology 1993;132:1176–1183.
   PubMed Web of Science ®Google Scholar
• Spicer LJ, Stewart RE, Alvarez P, Francisco CC, Keefer BE. Insulin-like growth factor-binding protein-2 and -3: their biological effects in bovine thecal cells. Biol Reprod 1997;56:1458–1465.
   PubMed Web of Science ®Google Scholar
• Spicer LJ, Chamberlain CS. Insulin-like growth factor binding protein-3: its biological effect on bovine granulosa cells. Domest Anim Endocrinol 1999;16:19–29.
   PubMed Web of Science ®Google Scholar
• Dorn C, Reinsberg J, Kupka M, van der Ven H, Schild RL. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization. Arch Gynecol Obstet 2003;268:187–193.
   PubMedGoogle Scholar
• Hardouin S, Gourmelen M, Noguiez P, Seurin D, Roghani M, Le Bouc Y, Povoa G, et al. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 1989;69:1291–1301.
   PubMed Web of Science ®Google Scholar
• Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 1988;122:2150–2157.
   PubMed Web of Science ®Google Scholar
• Knauer DJ, Smith GL. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 1980;77:7252–7256.
   PubMed Web of Science ®Google Scholar
• Andress DL. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am J Physiol 1998;274:E744–E750.
   Google Scholar
• Stanek MB, Borman SM, Molskness TA, Larson JM, Stouffer RL, Patton PE. Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women. J Clin Endocrinol Metab 2007;92:2726–2733.
   PubMed Web of Science ®Google Scholar
• Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996;98:2612–2615.
   PubMed Web of Science ®Google Scholar